Abstract:Vascular dementia (VaD) is recognised as a neurocognitive disorder, which is explained by numerous vascular causes in the general absence of other pathologies. The heterogeneity of cerebrovascular disease makes it challenging to elucidate the neuropathological substrates and mechanisms of VaD as well as vascular cognitive impairment (VCI). Consensus and accurate diagnosis of VaD relies on wide-ranging clinical, neuropsychometric and neuroimaging measures with subsequent pathological confirmation. Pathological diagnosis of suspected clinical VaD requires adequate postmortem brain sampling and rigorous assessment methods to identify important substrates. Factors that define the subtypes of VaD include the nature and extent of vascular pathologies, degree of involvement of extra and intracranial vessels and the anatomical location of tissue changes. Atherosclerotic and cardioembolic diseases appear the most common substrates of vascular brain injury or infarction. Small vessel disease characterised by arteriolosclerosis and lacunar infarcts also causes cortical and subcortical microinfarcts, which appear to be the most robust substrates of cognitive impairment. Diffuse WM changes with loss of myelin and axonal abnormalities are common to almost all subtypes of VaD. Medial temporal lobe and hippocampal atrophy accompanied by variable hippocampal sclerosis are also features of VaD as they are of Alzheimer’s disease. Recent observations suggest that there is a vascular basis for neuronal atrophy in both the temporal and frontal lobes in VaD that is entirely independent of any Alzheimer pathology. Further knowledge on specific neuronal and dendro-synaptic changes in key regions resulting in executive dysfunction and other cognitive deficits, which define VCI and VaD, needs to be gathered. Hereditary arteriopathies such as cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy or CADASIL have provided insights into the mechanisms of dementia associated with cerebral small vessel disease. Greater understanding of the neurochemical and molecular investigations is needed to better define microvascular disease and vascular substrates of dementia. The investigation of relevant animal models would be valuable in exploring the pathogenesis as well as prevention of the vascular causes of cognitive impairment.

Neurobiochemical Mechanisms of Vascular Dementia

Mechanisms of glutamate metabolic function and dysfunction in vascular dementia

Cerebral Microvascular Dysfunction and Neurodegeneration in Dementia

Pharmacological Treatment of Vascular Dementia: A Molecular Mechanism Perspective

Pathological changes in neurovascular units: Lessons from cases of vascular dementia

Research update on the etiology and pathogenesis of vascular dementia

Vascular Dementia: A Microglia's Perspective.

Neuropeptides as Potential Biomarkers in Vascular Dementia

Mechanisms of acupuncture on vascular dementia—A review of animal studies

Exploring the therapeutic implications of natural compounds modulating apoptosis in vascular dementia

Application and Progress of Carnosine in Treatment of Vascular Dementia

Systemic and Disease-Specific Risk Factors in Vascular Dementia: Diagnosis and Prevention

Neurovascular dysfunction, inflammation and endothelial activation: Implications for the pathogenesis of Alzheimer's disease

Cholinergic deficiency involved in vascular dementia: possible mechanism and strategy of treatment

Vascular Dementia: From Pathobiology to Emerging Perspectives

Inflammation, apoptosis and autophagy as critical players in vascular dementia

Differential involvement of central and peripheral catecholamines between Alzheimer's disease and vascular dementia

Vascular dementia: prevention and treatment

Dysfunction of Cerebrovascular Endothelial Cells: Prelude to Vascular Dementia

The Roles of Nitric Oxide Synthase/Nitric Oxide Pathway in the Pathology of Vascular Dementia and Related Therapeutic Approaches

Neuropathological diagnosis of vascular cognitive impairment and vascular dementia with implications for Alzheimer’s disease